Literature DB >> 15831901

Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.

V Morgan1, D Pickens, S Gautam, R Kessler, H Mertz.   

Abstract

BACKGROUND AND AIMS: Irritable bowel syndrome (IBS) is a disorder of intestinal hypersensitivity and altered motility, exacerbated by stress. Functional magnetic resonance imaging (fMRI) during painful rectal distension in IBS has demonstrated greater activation of the anterior cingulate cortex (ACC), an area relevant to pain and emotions. Tricyclic antidepressants are effective for IBS. The aim of this study was to determine if low dose amitriptyline reduces ACC activation during painful rectal distension in IBS to confer clinical benefits. Secondary aims were to identify other brain regions altered by amitriptyline, and to determine if reductions in cerebral activation are greater during mental stress.
METHODS: Nineteen women with painful IBS were randomised to amitriptyline 50 mg or placebo for one month and then crossed over to the alternate treatment after washout. Cerebral activation during rectal distension was compared between placebo and amitriptyline groups by fMRI. Distensions were performed alternately during auditory stress and relaxing music.
RESULTS: Rectal pain induced significant activation of the perigenual ACC, right insula, and right prefrontal cortex. Amitriptyline was associated with reduced pain related cerebral activations in the perigenual ACC and the left posterior parietal cortex, but only during stress.
CONCLUSIONS: The tricyclic antidepressant amitriptyline reduces brain activation during pain in the perigenual (limbic) anterior cingulated cortex and parietal association cortex. These reductions are only seen during stress. Amitriptyline is likely to work in the central nervous system rather than peripherally to blunt pain and other symptoms exacerbated by stress in IBS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831901      PMCID: PMC1774484          DOI: 10.1136/gut.2004.047423

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  48 in total

1.  Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation.

Authors:  T H Svensson; T Usdin
Journal:  Science       Date:  1978-12-08       Impact factor: 47.728

2.  Immunological changes in young and old adults during brief laboratory stress.

Authors:  B D Naliboff; D Benton; G F Solomon; J E Morley; J L Fahey; E T Bloom; T Makinodan; S L Gilmore
Journal:  Psychosom Med       Date:  1991 Mar-Apr       Impact factor: 4.312

3.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

Authors:  P Welgan; H Meshkinpour; M Beeler
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

4.  Effects of desipramine on irritable bowel syndrome compared with atropine and placebo.

Authors:  D S Greenbaum; J E Mayle; L E Vanegeren; J A Jerome; J W Mayor; R B Greenbaum; R W Matson; G E Stein; H A Dean; N A Halvorsen
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

Review 5.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.

Authors:  G P Chrousos; P W Gold
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

6.  Symptoms and visceral perception in severe functional and organic dyspepsia.

Authors:  H Mertz; S Fullerton; B Naliboff; E A Mayer
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

8.  Tolerance for rectosigmoid distention in irritable bowel syndrome.

Authors:  W E Whitehead; B Holtkotter; P Enck; R Hoelzl; K D Holmes; J Anthony; H S Shabsin; M M Schuster
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

9.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Brain activity during transient sadness and happiness in healthy women.

Authors:  M S George; T A Ketter; P I Parekh; B Horwitz; P Herscovitch; R M Post
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

View more
  84 in total

Review 1.  When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain.

Authors:  Madhusudan Grover
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 2.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

Review 3.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

4.  Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists.

Authors:  D A Drossman
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 5.  Role of neuroimaging in analgesic drug development.

Authors:  Jane Lawrence; Sean C Mackey
Journal:  Drugs R D       Date:  2008

Review 6.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

7.  Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study.

Authors:  Qi Pauls; Valerie Durkalski-Mauldin; Olga Brawman-Mintzer; Chris Lawrence; Rebekah Whichard; Peter B Cotton
Journal:  Dig Dis Sci       Date:  2016-05-10       Impact factor: 3.199

8.  Cerebral processing of auditory stimuli in patients with irritable bowel syndrome.

Authors:  Viola Andresen; Alexander Poellinger; Chedwa Tsrouya; Dominik Bach; Albrecht Stroh; Annette Foerschler; Petra Georgiewa; Marco Schmidtmann; Ivo R van der Voort; Peter Kobelt; Claus Zimmer; Bertram Wiedenmann; Burghard F Klapp; Hubert Monnikes
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

Review 10.  Studying the brain-gut axis with pharmacological imaging.

Authors:  Kirsten Tillisch; Zhuo Wang; Lisa Kilpatrick; Daniel P Holschneider; Emeran A Mayer
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.